Clinical Trials Conditions Media Tincture 
FloridaMarijuana.net
JUNE 13, 2018
Mainstream media has begun to illustrate just how effective medical marijuana can be in helping cancer patients. The American Cancer Society reported that studies have consistently shown that during clinical trials patients who used marijuana extracts needed less pain medicine and opioids.
Cannabis Law Report
JULY 24, 2019
Curaleaf CURLF, -7.27% is “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases,” the FDA wrote. Full report at. Full Letter. Source: [link].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
OCTOBER 29, 2021
The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease.
The Cannigma
JUNE 24, 2021
While many health conditions can be treated with more traditional pharmaceuticals, plant-based products may be a safer and healthier option – or at least a safe health supplement. By interacting with the receptors of the ECS, cannabis modulates the bodily functions that cause or exacerbate health conditions.
The Joint Blog
JULY 25, 2020
Lately, CBD has warranted a huge share of public and media attention for its perceived benefits to health and well-being. The agency maintains that they need more time to probe further into the science of cannabidiol, which will require thorough research and clinical trials before they can conclude certain products as GRAS. “To
Cannabis Law Report
JULY 23, 2019
LGC and its investors will benefit from a substantial competitive advantage through their knowledge and clinical trial capacity and its capacity to handle the regulatory compliance process for pharmaceuticals and food products,” said Mazen Haddad, CEO of LGC. Media – Kellie Coppin: kcoppin@renmarkfinancial.com.
Project CBD
FEBRUARY 28, 2023
The combined total from both channels — $58,293,034 — does not include CBD sales in licensed cannabis dispensaries or CBD products, such as vapes, tinctures, gummies, and other edibles sold online. (E-commerce Available at: www.fda.gov/media/131878/download. E-commerce sales of CBD in the U.S. Accessed October 17, 2022.
Expert insights. Personalized for you.
189 
Let's personalize your content